当前位置:首页 - 行情中心 - 博济医药(300404) - 财务分析 - 资产负债表

博济医药

(300404)

  

流通市值:25.54亿  总市值:35.40亿
流通股本:2.76亿   总股本:3.82亿

资产负债表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
流动资产:
货币资金132,940,785.41328,171,927.87219,203,571.24397,162,338.25
应收票据及应收账款173,458,968.72157,489,660.63154,235,520.61115,918,601.47
其中:应收票据6,023,5502,818,618.41,316,2351,502,610.32
应收账款167,435,418.72154,671,042.23152,919,285.61114,415,991.15
预付款项22,862,514.5321,942,098.622,620,936.9524,726,527.56
其他应收款合计9,468,672.778,298,851.8610,099,881.057,894,016.75
存货228,267,247.47217,452,514.32213,131,599.5199,074,592.6
合同资产94,875,576.4665,399,760.955,376,056.5561,147,251.28
其他流动资产1,828,190.182,916,918.372,202,949.511,884,276.48
流动资产平衡项目0000
流动资产合计812,494,881.98849,704,092.06826,383,094.63815,183,866.44
非流动资产:
长期股权投资6,978,057.446,209,744.684,227,827.634,327,570.17
其他权益工具投资51,605,16651,605,16651,605,16651,605,166
其他非流动金融资产91,710,347.5957,610,347.5958,104,756.0558,104,756.05
投资性房地产125,121,246.790,046,867.9489,106,884.7545,253,432.35
固定资产247,946,248.13285,777,264.82291,133,140.73209,198,618.4
在建工程517,163.181,109,916.011,223,855.88120,602,683.8
使用权资产4,121,639.676,424,829.474,283,019.594,943,159.65
无形资产21,523,970.4821,444,700.8621,685,89921,927,097.14
商誉28,098,558.0328,098,558.0328,098,558.0328,098,558.03
长期待摊费用18,323,963.1617,780,752.515,681,577.2916,238,076.11
递延所得税资产66,195,153.8162,690,490.9251,788,592.948,130,868.15
其他非流动资产8,621,260.279,541,954.677,727,912.315,313,222.83
非流动资产平衡项目0000
非流动资产合计670,762,774.46638,340,593.49624,667,190.16613,743,208.68
资产平衡项目0000
资产总计1,483,257,656.441,488,044,685.551,451,050,284.791,428,927,075.12
流动负债:
短期借款27,035,00029,977,680.3330,877,680.3329,877,680.33
应付票据及应付账款149,639,915.29117,649,403.99112,976,835.59101,449,302.75
应付账款149,639,915.29117,649,403.99112,976,835.59101,449,302.75
合同负债182,191,223.71190,006,361.72169,417,557.37173,565,633.65
应付职工薪酬21,854,748.5821,695,925.6721,333,347.9219,875,723.92
应交税费12,872,976.839,081,096.6710,169,523.747,505,866.58
其他应付款合计14,207,723.1814,521,098.6815,006,519.7414,521,165.02
应付股利14,00014,000--
一年内到期的非流动负债3,378,310.825,409,038.344,111,015.044,005,552.57
其他流动负债6,656,713.027,652,294.676,737,098.656,709,441.39
流动负债平衡项目0000
流动负债合计417,836,611.43395,992,900.07370,629,578.38357,510,366.21
非流动负债:
长期借款39,264,235.8579,688,406.7280,946,711.5174,633,855.38
租赁负债2,410,852.93,777,339.312,590,078.963,103,266.15
预计负债377,000377,000377,000377,000
递延收益5,816,732.366,200,032.266,676,775.517,475,190.48
递延所得税负债6,146,250.456,536,382.95,894,922.495,720,219.99
非流动负债平衡项目0000
非流动负债合计54,015,071.5696,579,161.1996,485,488.4791,309,532
负债平衡项目0000
负债合计471,851,682.99492,572,061.26467,115,066.85448,819,898.21
所有者权益(或股东权益):
实收资本(或股本)382,207,238382,207,238382,005,238381,996,238
资本公积364,765,254.29365,091,382.85362,661,961.08361,565,055.36
减:库存股19,459,113.8119,459,113.8119,475,113.814,376,000
其他综合收益2,615,193.293,113,615.433,544,291.412,980,679.93
盈余公积27,166,412.7127,166,412.7127,166,412.7127,166,412.71
未分配利润225,994,694.73212,852,089.47203,033,434.46186,520,342.28
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计983,289,679.21970,971,624.65958,936,223.85955,852,728.28
少数股东权益28,116,294.2424,500,999.6424,998,994.0924,254,448.63
股东权益平衡项目0000
股东权益合计1,011,405,973.45995,472,624.29983,935,217.94980,107,176.91
负债和股东权益合计1,483,257,656.441,488,044,685.551,451,050,284.791,428,927,075.12
公告日期2024-10-262024-08-272024-04-252024-04-25
审计意见(境内)标准无保留意见
TOP↑